These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9871717)

  • 1. Discovery of L-755,507: a subnanomolar human beta 3 adrenergic receptor agonist.
    Parmee ER; Ok HO; Candelore MR; Tota L; Deng L; Strader CD; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 1998 May; 8(9):1107-12. PubMed ID: 9871717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent, selective benzenesulfonamide agonists of the human beta 3 adrenergic receptor.
    Weber AE; Mathvink RJ; Perkins L; Hutchins JE; Candelore MR; Tota L; Strader CD; Wyvratt MJ; Fisher MH
    Bioorg Med Chem Lett; 1998 May; 8(9):1101-6. PubMed ID: 9871716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Pyridylethanolamines: potent and selective human beta 3 adrenergic receptor agonists.
    Naylor EM; Colandrea VJ; Candelore MR; Cascieri MA; Colwell LF; Deng L; Feeney WP; Forrest MJ; Hom GJ; MacIntyre DE; Strader CD; Tota L; Wang PR; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 1998 Nov; 8(21):3087-92. PubMed ID: 9873681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Pyridyloxypropanolamine agonists of the beta 3 adrenergic receptor with improved pharmacokinetic properties.
    Weber AE; Ok HO; Alvaro RF; Candelore MR; Cascieri MA; Chiu SH; Deng L; Forrest MJ; Hom GJ; Hutchins JE; Kao J; MacIntyre DE; Mathvink RJ; McLoughlin D; Miller RR; Newbold RC; Olah TV; Parmee ER; Perkins L; Stearns RA; Strader CD; Szumiloski J; Tang YS; Tota L; Fisher MH
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2111-6. PubMed ID: 9873496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptamine-based human beta3-adrenergic receptor agonists. Part 1: SAR studies of the 7-position of the indole ring.
    Mizuno K; Sawa M; Harada H; Tateishi H; Oue M; Tsujiuchi H; Furutani Y; Kato S
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5959-62. PubMed ID: 15546707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide.
    Mathvink RJ; Tolman JS; Chitty D; Candelore MR; Cascieri MA; Colwell LF; Deng L; Feeney WP; Forrest MJ; Hom GJ; MacIntyre DE; Miller RR; Stearns RA; Tota L; Wyvratt MJ; Fisher MH; Weber AE
    J Med Chem; 2000 Oct; 43(21):3832-6. PubMed ID: 11052788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human beta3 adrenergic receptor agonists.
    Parmee ER; Brockunier LL; He J; Singh SB; Candelore MR; Cascieri MA; Deng L; Liu Y; Tota L; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2283-6. PubMed ID: 11055339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted oxazole benzenesulfonamides as potent human beta3 adrenergic receptor agonists.
    Ok HO; Reigle LB; Candelore MR; Cascieri MA; Colwell LF; Deng L; Feeney WP; Forrest MJ; Hom GJ; MacIntyre DE; Strader CD; Tota L; Wang P; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 2000 Jul; 10(14):1531-4. PubMed ID: 10915043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides.
    Parmee ER; Naylor EM; Perkins L; Colandrea VJ; Ok HO; Candelore MR; Cascieri MA; Deng L; Feeney WP; Forrest MJ; Hom GJ; MacIntyre DE; Miller RR; Stearns RA; Strader CD; Tota L; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 1999 Mar; 9(5):749-54. PubMed ID: 10201841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent and selective human beta(3)-adrenergic receptor antagonists.
    Candelore MR; Deng L; Tota L; Guan XM; Amend A; Liu Y; Newbold R; Cascieri MA; Weber AE
    J Pharmacol Exp Ther; 1999 Aug; 290(2):649-55. PubMed ID: 10411574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptamine-based human beta3-adrenergic receptor agonists. Part 2: SAR of the methylene derivatives.
    Sawa M; Tateishi H; Mizuno K; Harada H; Oue M; Tsujiuchi H; Furutani Y; Kato S
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5963-6. PubMed ID: 15546708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (4-Piperidin-1-yl)phenyl amides: potent and selective human beta(3) agonists.
    Hu B; Ellingboe J; Han S; Largis E; Mulvey R; Oliphant A; Sum FW; Tillett J
    J Med Chem; 2001 Apr; 44(9):1456-66. PubMed ID: 11311069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel (4-piperidin-1-yl)-phenyl sulfonamides as potent and selective human beta(3) agonists.
    Hu B; Ellingboe J; Han S; Largis E; Lim K; Malamas M; Mulvey R; Niu C; Oliphant A; Pelletier J; Singanallore T; Sum FW; Tillett J; Wong V
    Bioorg Med Chem; 2001 Aug; 9(8):2045-59. PubMed ID: 11504641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agents.
    Biftu T; Feng DD; Liang GB; Kuo H; Qian X; Naylor EM; Colandrea VJ; Candelore MR; Cascieri MA; Colwell LF; Forrest MJ; Hom GJ; MacIntyre DE; Stearns RA; Strader CD; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 2000 Jul; 10(13):1431-4. PubMed ID: 10888325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenoceptor subtypes and their desensitization mechanisms.
    Summers RJ; Kompa A; Roberts SJ
    J Auton Pharmacol; 1997 Dec; 17(6):331-43. PubMed ID: 9610428
    [No Abstract]   [Full Text] [Related]  

  • 16. Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides.
    Naylor EM; Parmee ER; Colandrea VJ; Perkins L; Brockunier L; Candelore MR; Cascieri MA; Colwell LF; Deng L; Feeney WP; Forrest MJ; Hom GJ; MacIntyre DE; Strader CD; Tota L; Wang PR; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 1999 Mar; 9(5):755-8. PubMed ID: 10201842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres.
    Uehling DE; Donaldson KH; Deaton DN; Hyman CE; Sugg EE; Barrett DG; Hughes RG; Reitter B; Adkison KK; Lancaster ME; Lee F; Hart R; Paulik MA; Sherman BW; True T; Cowan C
    J Med Chem; 2002 Jan; 45(3):567-83. PubMed ID: 11806709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of 3D-QSAR models in cyclic ureidobenzenesulfonamides: human beta3-adrenergic receptor agonist.
    Kashaw SK; Rathi L; Mishra P; Saxena AK
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2481-4. PubMed ID: 12852947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and selective, sulfamide-based human beta 3-adrenergic receptor agonists.
    Dow RL; Paight ES; Schneider SR; Hadcock JR; Hargrove DM; Martin KA; Maurer TS; Nardone NA; Tess DA; DaSilva-Jardine P
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3235-40. PubMed ID: 15149682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium.
    Pott C; Brixius K; Bundkirchen A; Bölck B; Bloch W; Steinritz D; Mehlhorn U; Schwinger RH
    Br J Pharmacol; 2003 Feb; 138(3):521-9. PubMed ID: 12569077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.